Clinical Trial

The Extended Study of Prevalence of Infection in Intensive Care IV

Study acronym: EPIC IV
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to learn how common infections are in intensive care units (ICUs) around the world and how they are treated. The study will look at all adults in the ICU during a single 24-hour period. The main questions it aims to answer are: * What types of infections and antibiotic-resistant bacteria are most common in ICUs worldwide? * How do resistance patterns affect how participants are treated and how they recover? How are antibiotics used in ICUs, and how do hospitals practice antibiotic stewardship? * What organ support treatments do participants with infections receive? * What are the outcomes of participants with severe infections, including survival at hospital discharge (up to 60 days)? Researchers will compare ICUs across regions and income levels to see how infection patterns, treatments, and outcomes differ around the world. Participants will: * Be counted if they are present in the ICU at any time during the study day. * Have information collected from their medical record about their health, the infection they may have, treatments they receive, and their outcome at ICU and hospital discharge (up to 60 days). Because this is an observational study, participants will not receive any new treatments as part of the study.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-03 -> 2027-05 2026-06-30
minor Completion pushed: 2026-05 -> 2027-06 2026-06-30
Trial Details
NCT Number NCT07309549
Lead Sponsor Universidad de la Sabana
Conditions Sepsis, Infection
Enrollment 10,000 participants
Start Date 2027-02-01
Primary Completion 2027-05 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2026-06-29